NCT03439605

Brief Summary

This study will be investigating how a common blood test for identifying heart damage (Troponin T) is affected by red blood cell damage in the blood sample (Haemolysis). It is already known that damage to the red blood cells during or after blood sample collection can cause falsely low test results however the exact amount is not clear. Some previous studies suggest that a much higher amount of red blood cell damage could be allowable when reporting the test results. This study will mimic the type of red blood cell damage that occurs in the hospital and determine what degree of damage or 'haemolysis' causes a significant reduction in the test result and therefore determine an allowable limit for safely reporting the test result. The results of this study may help provide an evidence based approach to improving current practice and may lead to fewer rejected blood samples, fewer repeat tests, improved A\&E treatment times, general cost savings and an improved service to patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 5, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 20, 2018

Completed
Last Updated

February 20, 2018

Status Verified

February 1, 2018

Enrollment Period

3 months

First QC Date

February 5, 2018

Last Update Submit

February 19, 2018

Conditions

Keywords

Troponin-THaemolysis

Outcome Measures

Primary Outcomes (1)

  • The difference in measured hs-cTnT between baseline and the haemolysis groups.

    Day one

Secondary Outcomes (1)

  • The Percentage change in hs-cTnT due to haemolysis at five groups of different troponin T levels.

    Day one

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients attending Poole emergency department having High Sensitivity Troponin T measurements performed on their blood as part of their medical investigations.

You may qualify if:

  • Adult patients attending Poole emergency department having High Sensitivity Troponin T measurements performed on their blood as part of their medical investigations.

You may not qualify if:

  • Serum samples with Haemolysis Index \>20.
  • Serum High sensitivity Troponin T result \<5 ng/l and \>100 ng/l
  • Patients lacking capacity to give verbal consent.
  • Under 18 years of age.
  • Patient has previously been approached about this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Poole Hospital NHSFT

Poole, Dorset, BH15 2JB, United Kingdom

Location

MeSH Terms

Conditions

Hemolysis

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2018

First Posted

February 20, 2018

Study Start

September 9, 2017

Primary Completion

December 6, 2017

Study Completion

December 6, 2017

Last Updated

February 20, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations